Zobrazeno 1 - 10
of 85
pro vyhledávání: '"for the Icona Foundation Study Group […"'
Autor:
Milensu Shanyinde, Enrico Girardi, Massimo Puoti, Andrea De Luca, Laura Sighinolfi, Uberti Foppa Caterina, Pietro Caramello, Fiona C. Lampe, Antonella D’Arminio Monforte, Alessandro Cozzi-Lepri, for the ICONA Foundation Study Group
Publikováno v:
BMC Public Health, Vol 19, Iss 1, Pp 1-13 (2019)
Abstract Background Alcohol consumption is a known risk factor for liver disease in HIV-infected populations. Therefore, knowledge of alcohol consumption behaviour and risk of disease progression associated with hazardous drinking are important in th
Externí odkaz:
https://doaj.org/article/3bf4fae4a7754aea98e4d74f4e7c61e5
Autor:
Annalisa Saracino, Mauro Zaccarelli, Patrizia Lorenzini, Alessandra Bandera, Giulia Marchetti, Francesco Castelli, Andrea Gori, Enrico Girardi, Cristina Mussini, Paolo Bonfanti, Adriana Ammassari, Antonella d’Arminio Monforte, for the Icona Foundation Study Group
Publikováno v:
BMC Public Health, Vol 18, Iss 1, Pp 1-12 (2018)
Abstract Background Social determinants are known to be a driving force of health inequalities, even in high income countries. Aim of our study was to determine if these factors can limit antiretroviral therapy (ART) access, outcome and retention in
Externí odkaz:
https://doaj.org/article/5d6636b929e64d0b855cab5a2c56d9f7
Autor:
Cristina Mussini, Patrizia Lorenzini, Alessandro Cozzi-Lepri, Giulia Marchetti, Stefano Rusconi, Andrea Gori, Silvia Nozza, Miriam Lichtner, Andrea Antinori, Andrea Cossarizza, Antonella d’Arminio Monforte, for the Icona Foundation Study Group
Publikováno v:
BMC Medicine, Vol 16, Iss 1, Pp 1-10 (2018)
Abstract Background The CD4/CD8 ratio has been associated with the risk of AIDS and non-AIDS events. We describe trends in immunological parameters in people who underwent a switch to monotherapy or dual therapy, compared to a control group remaining
Externí odkaz:
https://doaj.org/article/fa7a7617537a411bb97260c6e5cb40f3
Autor:
Antonella Cingolani, Alessandro Cozzi Lepri, Luciana Teofili, Laura Galli, Valentina Mazzotta, Gian Maria Baldin, Stefan Hohaus, Alessandra Bandera, Lucia Alba, Nadia Galizzi, Antonella Castagna, Antonella D'arminio Monforte, Andrea Antinori, ICONA Foundation Study group
Publikováno v:
PLoS ONE, Vol 12, Iss 10, p e0186549 (2017)
to compare overall survival in HIV-associated lymphoma (HIV-L) and lymphoma raising in HIV-negative population (nHIV-L) and to identify predictors of increased risk of death.All HIV+ patients with HIV-associated lymphoma (Hodgkin lymphoma, HL; non-Ho
Externí odkaz:
https://doaj.org/article/abf45ea9597b4c47b2cc7b9c7f94deb5
Autor:
Silvia Nozza, Alessandro Cozzi-Lepri, Francesca Bai, Stefano Rusconi, Andrea Gori, Paola Cinque, Adriana Ammassari, Pietro Caramello, Giuseppe Tambussi, Antonella D'Arminio Monforte, Giulia Marchetti, Icona Foundation Study Group
Publikováno v:
PLoS ONE, Vol 12, Iss 12, p e0189045 (2017)
In Italy the prevalence of recent HIV infection (RHI) isn't currently monitored. Early diagnosis is crucial to allow introduction of antiretroviral therapy (cART) in the recent phase of infection. We aimed to estimate the proportion and the determina
Externí odkaz:
https://doaj.org/article/1672aadcebcb417a9927a6407b66605b
Autor:
Silvia Costarelli, Alessandro Cozzi-Lepri, Giuseppe Lapadula, Stefano Bonora, Giordano Madeddu, Franco Maggiolo, Andrea Antinori, Massimo Galli, Giovanni Di Perri, Pierluigi Viale, Antonella d'Arminio Monforte, Andrea Gori, ICONA Foundation Study Group
Publikováno v:
PLoS ONE, Vol 11, Iss 10, p e0160761 (2016)
In clinical trials, toxicity leading to tenofovir disoproxil fumarate (TDF) discontinuation is rare (3% by 2 years); however in clinical practice it seems to be higher, particularly when TDF is co-administered with ritonavir-boosted protease inhibito
Externí odkaz:
https://doaj.org/article/deb16332eff9450e997aa3ac9df7f855
Autor:
Alessandra Bandera, Andrea Gori, Francesca Sabbatini, Giordano Madeddu, Stefano Bonora, Raffaella Libertone, Claudio Mastroianni, Paolo Bonfanti, Antonella d'Arminio Monforte, Alessandro Cozzi-Lepri, Icona Foundation Study Group
Publikováno v:
PLoS ONE, Vol 10, Iss 5, p e0124252 (2015)
Whilst renal dysfunction, especially mild impairment (6090, 60-89, 90, 60-89,
Externí odkaz:
https://doaj.org/article/ca950dd7671044bc96b063ca3219045d
Autor:
Cristina Mussini, Patrizia Lorenzini, Massimo Puoti, Miriam Lichtner, Giuseppe Lapadula, Simona Di Giambenedetto, Andrea Antinori, Giordano Madeddu, Alessandro Cozzi-Lepri, Antonella d'Arminio Monforte, Andrea De Luca, ICONA Foundation Study Group
Publikováno v:
PLoS ONE, Vol 10, Iss 12, p e0140877 (2015)
To evaluate the Fibrosis (FIB)-4 index as a predictor of major liver-related events (LRE) and liver-related death (LRD) in human immunodeficiency virus (HIV) type-1 patients initiating combination antiretroviral therapy (cART).Retrospective analysis
Externí odkaz:
https://doaj.org/article/eb303d474b004369981dbfd7fc017132
Autor:
Silvia, Nozza, Laura, Timelli, Annalisa, Saracino, Nicola, Gianotti, Claudia, Lazzaretti, Alessandro, Tavelli, Massimo, Puoti, Sergio, Lo Caputo, Andrea, Antinori, Antonella d'Arminio, Monforte, Cristina, Mussini, Enrico, Girardi, On Behalf Of Icona Foundation Study Group
Publikováno v:
Journal of Clinical Medicine
Journal of Clinical Medicine, Vol 10, Iss 3391, p 3391 (2021)
Volume 10
Issue 15
Journal of Clinical Medicine, Vol 10, Iss 3391, p 3391 (2021)
Volume 10
Issue 15
Background: We aimed to describe the change in the incidence and causes of hospitalization between 2008 and 2018 among persons living with HIV (PLWHIV) who started antiretroviral therapy (ART) from 2008 onwards in Italy. Methods: We included particip
Autor:
Antonella Cingolani, Alessandro Cozzi-Lepri, Adriana Ammassari, Cristina Mussini, Maria Alessandra Ursitti, Pietro Caramello, Gioacchino Angarano, Paolo Bonfanti, Andrea De Luca, Maria Stella Mura, Enrico Girardi, Andrea Antinori, Antonela D'Arminio Monforte, Icona Foundation Study group
Publikováno v:
PLoS ONE, Vol 9, Iss 2, p e89861 (2014)
BackgroundTime of starting antiretroviral therapy (ART) after diagnosis of specific AIDS-defining event (ADE) is a crucial aspect. Objectives of this study were to evaluate if in patients diagnosed with ADE the time to ART initiation may vary accordi
Externí odkaz:
https://doaj.org/article/5afd235b4af74ee0a932b2ca899af9de